Fig. 1: Event free survival of patients with B-cell precursor ALL and MEF2D rearrangements stratified by partner gene, period of diagnosis, NCI risk group and ethnicity.
All event free survival rates are quoted at 5 years with accompanying 95% Confidence Intervals. HR hazard ratio, NCI National Cancer Institute.
